These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 28712776)

  • 21. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Endometrial carcinoma and precursor lesions].
    Djordjević B; Stanojević Z
    Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discordant loss of mismatch repair proteins in advanced endometrial endometrioid carcinoma compared to paired primary uterine tumors.
    Ta RM; Hecht JL; Lin DI
    Gynecol Oncol; 2018 Dec; 151(3):401-406. PubMed ID: 30340772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia.
    Vetter MH; Smith B; Benedict J; Hade EM; Bixel K; Copeland LJ; Cohn DE; Fowler JM; O'Malley D; Salani R; Backes FJ
    Am J Obstet Gynecol; 2020 Jan; 222(1):60.e1-60.e7. PubMed ID: 31401259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congruence Between 1994 WHO Classification of Endometrial Hyperplasia and Endometrial Intraepithelial Neoplasia System.
    Travaglino A; Raffone A; Saccone G; Mascolo M; Guida M; Mollo A; Insabato L; Zullo F
    Am J Clin Pathol; 2020 Jan; 153(1):40-48. PubMed ID: 31433834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups.
    Miller EM; Patterson NE; Gressel GM; Karabakhtsian RG; Bejerano-Sagie M; Ravi N; Maslov A; Quispe-Tintaya W; Wang T; Lin J; Smith HO; Goldberg GL; Kuo DYS; Montagna C
    BMC Med Genomics; 2020 Nov; 13(1):179. PubMed ID: 33256706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular Analysis of Mixed Endometrial Carcinomas Shows Clonality in Most Cases.
    Köbel M; Meng B; Hoang LN; Almadani N; Li X; Soslow RA; Gilks CB; Lee CH
    Am J Surg Pathol; 2016 Feb; 40(2):166-180. PubMed ID: 26492180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma.
    García-Sanz P; Triviño JC; Mota A; Pérez López M; Colás E; Rojo-Sebastián A; García Á; Gatius S; Ruiz M; Prat J; López-López R; Abal M; Gil-Moreno A; Reventós J; Matias-Guiu X; Moreno-Bueno G
    Int J Cancer; 2017 Apr; 140(7):1551-1563. PubMed ID: 27997699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical expression of PTEN and beta-catenin for endometrial intraepithelial neoplasia in Japanese women.
    Norimatsu Y; Moriya T; Kobayashi TK; Sakurai T; Shimizu K; Tsukayama C; Ohno E
    Ann Diagn Pathol; 2007 Apr; 11(2):103-8. PubMed ID: 17349568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of coexistent carcinomas risks by subjective EIN diagnosis and comparison with WHO classification in endometrial hyperplasias.
    Yang YF; Liao YY; Peng NF; Li LQ; Xie SR; Wang RB
    Pathol Res Pract; 2012 Dec; 208(12):708-12. PubMed ID: 23044462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphological diagnosis of endometrial intraepithelial neoplasia and expression of PTEN].
    Zhou WX; Liang ZY; Gao J; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2009 Jun; 38(6):393-6. PubMed ID: 19781346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of ovarian hyperthecosis with endometrial polyp, endometrial hyperplasia, and endometrioid adenocarcinoma in postmenopausal women: a clinicopathological study of 238 cases.
    Zhang C; Sung CJ; Quddus MR; Simon RA; Jazaerly T; Lawrence WD
    Hum Pathol; 2017 Jan; 59():120-124. PubMed ID: 27746268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PI3K Pathway Effectors pAKT and FOXO1 as Novel Markers of Endometrioid Intraepithelial Neoplasia.
    Strickland AL; Rivera G; Lucas E; John G; Cuevas I; Castrillon DH
    Int J Gynecol Pathol; 2019 Nov; 38(6):503-513. PubMed ID: 30256235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.
    Peiró G; Peiró FM; Ortiz-Martínez F; Planelles M; Sánchez-Tejada L; Alenda C; Ceballos S; Sánchez-Payá J; Laforga JB
    Hum Pathol; 2013 Feb; 44(2):218-25. PubMed ID: 22955108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of molecular classification to guiding fertility-sparing therapy for patients with endometrial cancer or endometrial intraepithelial neoplasia.
    Zhang X; Chen D; Zhao X; Wang C; He Y; Chen Y; Wang J; Shen D
    Pathol Res Pract; 2023 Jan; 241():154278. PubMed ID: 36580798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endometrial intraepithelial neoplasia.
    Owings RA; Quick CM
    Arch Pathol Lab Med; 2014 Apr; 138(4):484-91. PubMed ID: 24678678
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and clinical significance of ghrelin in endometrial hyperplasia and carcinoma of Egyptian patients.
    Younes SF; Aiad H; Kandil M; El Kalashy FS
    Ultrastruct Pathol; 2015 May; 39(3):207-13. PubMed ID: 25569277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the prognostic role of ATR mutation in endometrioid endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
    Zighelboim I; Ali S; Lankes HA; Backes F; Moore K; Mutch D; Robison K; Behbakht K; Waggoner S; Ghebre RG; Pearl M; Ramirez NC; Goodfellow P
    Gynecol Oncol; 2015 Sep; 138(3):614-9. PubMed ID: 26144601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological Characteristics and
    Sung JY; Jung YY; Kim HS
    Anticancer Res; 2018 May; 38(5):2779-2786. PubMed ID: 29715099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strong correlation between molecular changes in endometrial carcinomas and concomitant hyperplasia.
    Zauber P; Denehy TR; Taylor RR; Ongcapin EH; Marotta S; Sabbath-Solitare M
    Int J Gynecol Cancer; 2015 Jun; 25(5):863-8. PubMed ID: 25768080
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.